2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)
- Status
- TERMINATED
- Phase
- N/A
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Platinum Rechallenge in Patients With Platinum-sensitive mTNBC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
- Status
- COMPLETED
- Phase
- PHASE2
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine
- Status
- COMPLETED
- Phase
- NA
Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Abraxane in Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2